Prokidney (PROK) Net Equity Issued and Repurchased (2022 - 2026)

Prokidney (PROK) has 4 years of Net Equity Issued and Repurchased data on file, last reported at $7000.0 in Q1 2026.

• On a quarterly basis, Net Equity Issued and Repurchased changed N/A year-over-year to $7000.0 in Q1 2026; TTM through Mar 2026 was $24.3 million, a N/A change from a year earlier, with the FY2025 full-year figure at $24.2 million, down 83.2% from the prior year.
• Net Equity Issued and Repurchased for Q1 2026 stood at $7000.0, down from $17.1 million in the prior quarter.
• Over the last five years, Net Equity Issued and Repurchased for PROK reached as high as $17.1 million in Q4 2025 and fell as low as -$542.5 million in Q4 2022.
• Historically, Net Equity Issued and Repurchased has averaged -$85.6 million across 4 years, with a median of $2.2 million in 2024.
• On a YoY basis, Net Equity Issued and Repurchased climbed as much as 571600.0% in 2025 and fell as far as 58.88% in 2025.
• Year by year, Net Equity Issued and Repurchased stood at -$542.5 million in 2022, then surged by 100.0% to -$3000.0 in 2024, then soared by 571600.0% to $17.1 million in 2025, then plunged by 99.96% to $7000.0 in 2026.
• Per Business Quant data, the three most recent Net Equity Issued and Repurchased figures were $7000.0 in Q1 2026, $17.1 million in Q4 2025, and $7.1 million in Q3 2025.